2 results
Approved WMOWill not start
The primary objective of this study is to determine if there is an improvement in progression-free survival(PFS) when siltuximab is added to VELCADE* (bortezomib) and dexamethasone in subjects with relapsedor refractory multiple myeloma.Theā¦
Approved WMOCompleted
The aim of this study is to measure the results of refractive surgery with aspherical intra-ocular lenses quickly and reliably.